Share on StockTwits

Stock Analysts’ ratings reiterations for Tuesday, September 2nd:

Abengoa, S.A. – American Depositary Shares (NASDAQ:ABGB) had its buy rating reissued by analysts at Canaccord Genuity. The firm currently has a $44.00 price target on the stock.

Buckeye Partners, L.P. (NYSE:BPL) had its buy rating reiterated by analysts at Argus. The firm currently has a $83.00 target price on the stock, up from their previous target price of $82.00.

Burlington Stores (NASDAQ:BURL) had its buy rating reiterated by analysts at Bank of America. The firm currently has a $40.00 target price on the stock.

Cheniere Energy Partners LP Holdings (NYSE:CQH) had its overweight rating reaffirmed by analysts at Barclays. They currently have a $31.00 target price on the stock, up from their previous target price of $29.00.

3D Systems (NYSE:DDD) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $65.00 price target on the stock, down from their previous price target of $70.00.

FormFactor (NASDAQ:FORM) had its neutral rating reissued by analysts at Citigroup Inc.. They currently have a $7.25 price target on the stock, up from their previous price target of $6.50.

Hawaiian Electric Industries (NYSE:HE) had its outperform rating reissued by analysts at Wells Fargo & Co..

Mattress Firm Holding Corp (NASDAQ:MFRM) had its buy rating reissued by analysts at Citigroup Inc.. They currently have a $65.00 target price on the stock, up from their previous target price of $63.00.

North Midland Construction plc (LON:NMD) had its corporate rating reissued by analysts at N+1 Singer.

Regeneron Pharmaceuticals (NASDAQ:REGN) had its equal weight rating reaffirmed by analysts at Morgan Stanley. Morgan Stanley currently has a $310.00 target price on the stock. The analysts wrote, “We believe positive data is already priced into REGN and expect minimal impact. While there could be some investor enthusiasm around the CV data, we do not believe alirocumab could differentiate itself from evolocumab on such a small study and further believe any positive CV data would be viewed as a class effect. Our ~$2B in 2020E WW alirocumab sales already reflects positive LDL lowering data, though we note positive outcomes data could double our ests. We look forward to any additional details on Regeneron and Sanofi’s 8:30 AM EST Tuesday conference call.”

Sally Beauty Holdings (NYSE:SBH) had its overweight rating reaffirmed by analysts at Morgan Stanley. The firm currently has a $30.00 target price on the stock. The analysts wrote, “We recently spent time with Chairman, President & CEO Gary Winterhalter & incoming CEO Chris Brickman (currently President & COO). We are encouraged by Mr. Brickman’s strategic vision, management style and areas of focus.While he does not have significant retail experience, his immersive approach to the business, CPG/consulting background and time spent on SBH’s Board suit him well for the role. Mr. Winterhalter’s continued involvement (Executive Chairman through Jan 2018) will be a valuable resource for Mr. Brickman and for the company.Several observations support our view.”

Spectra Energy Corp. (NYSE:SE) had its equal weight rating reaffirmed by analysts at Barclays. The firm currently has a $41.00 price target on the stock, up from their previous price target of $36.00.

Spectra Energy Partners, (NYSE:SEP) had its equal weight rating reiterated by analysts at Barclays. Barclays currently has a $55.00 price target on the stock, up from their previous price target of $53.00.

Signet Jewelers (NYSE:SIG) had its neutral rating reiterated by analysts at Citigroup Inc.. They currently have a $125.00 price target on the stock, up from their previous price target of $112.00.

Spirit AeroSystems Holdings (NYSE:SPR) had its buy rating reiterated by analysts at Citigroup Inc.. They currently have a $48.00 price target on the stock, up from their previous price target of $42.50.

Teradyne (NYSE:TER) had its buy rating reaffirmed by analysts at Citigroup Inc.. They currently have a $23.50 target price on the stock, up from their previous target price of $22.00.

Union Jack Oil PLC (LON:UJO) had its buy rating reiterated by analysts at SP Angel. They currently have a GBX 1 ($0.02) price target on the stock.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.